Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
6605 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2025-03-07 (nasdaq.com)
Biogen's Q4 Earnings & Sales Beat, 2025 EPS Guidance Disappoints |
BIIB's Q4 earnings and sales beat estimates. EPS guidance for 2025 falls short of expectations.
Read more
2025-01-16 (investing.com)
Biogen appoints new Chief Accounting Officer By
Biogen Inc. (NASDAQ: ), a leader in biotechnology, announced the appointment of Sean Godbout as Vice President, Chief Accounting Officer & Global Corporate Controller, effective March 1, 2025. The announcement, based on a recent SEC filing, indicates a strategic shift in the company's finance leadership as current Chief Financial Officer Michael McDonnell is set to retire on the same date.
Read more
2023-03-23 (fidelity.com)
Biogen Unusual Options Activity
A whale with a lot of money to spend has taken a noticeably bearish stance on Biogen. Looking at options history for Biogen we detected 12 strange trades.
Read more